Human Longevity, Inc. Expands $1 Million Cancer Prevention Pledge to Safeguard Against Late-Stage Ovarian Cancer

New pledge underscores confidence in early detection, supported by the Avantect® Liquid Biopsy and HLI's Executive Health Program SOUTH SAN FRANCISCO, Calif., July 17, 2025 /PRNewswire/ -- Human Longevity, Inc. (HLI), a global leader in precision medicine and proactive healthcare, today...